Nvidia Corp. NVDA CEO Jensen Huang is riding the artificial intelligence (AI) wave like no other, and now he has revealed the secret sauce of the tools he uses for research purposes every day.
What Happened: Huang revealed the two research tools he uses "almost every day" — Perplexity AI and Microsoft Corp.-backed MSFT OpenAI's ChatGPT. Coincidentally, both tools use Nvidia hardware.
Huang revealed this in an interview with Wired, underlining the popularity of ChatGPT as well as the recent rise of Perplexity.
While Perplexity is Huang's first preference, ChatGPT also found a mention amongst Huang's research tools. Interestingly enough, Alphabet Inc.'s GOOG GOOGL Google Gemini (previously Bard) was missing from the list.
"I've been using Perplexity. I enjoy ChatGPT as well. I use both almost every day," said Huang.
Huang revealed he uses Perplexity and ChatGPT for "research," including computer-aided drug discovery.
"Maybe you would like to know about the recent advancements in computer-aided drug discovery. And so you want to frame the overall topic so that you could have a framework, and from that framework, you could ask more and more specific questions."
Perplexity CEO was visibly satisfied with Huang's remarks. "Search like a billionaire (and probably soon, trillionaire.)"
Perplexity calls itself the "world's first conversational answer engine" instead of a simplistic AI chatbot like ChatGPT or Gemini.
It also lets users discover news and current affairs, something that its rivals ChatGPT and Gemini lack. It also allows users to choose between different AI models like GPT-4, Claude 2.1 or Perplexity itself, but that is a part of its "Pro" subscription that costs $20 per month or $200 per year.
Huang-led Nvidia has also led a recent $73.6 million funding round in Perplexity.
Check out more of Benzinga’s Consumer Tech coverage by following this link.
Photo courtesy: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
